Cellectar Biosciences, Inc.
CLRB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001279704
No open-market purchases or sales by Cellectar Biosciences, Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $9.08M in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Cellectar Biosciences, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 45 | 46 | +1 |
| Shares | 15.1M | 12.5M | −2.56M (−17.0%) |
| Value | $24.2M | $14.9M | −$9.35M (−38.6%) |
New holders (11)
Institutions that held Cellectar Biosciences, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| ACT Capital Management, LLC | 217,500 | $259.0K | 0.13% |
| State Street Corp | 147,846 | $176.0K | 0.00% |
| QS Investors, LLC | 142,400 | $170.0K | 0.00% |
| Monticello Wealth Management, LLC | 60,000 | $71.0K | 0.01% |
| Virtu Financial LLC | 49,780 | $59.0K | 0.01% |
| Sterneck Capital Management, LLC | 30,000 | $34.0K | 0.02% |
| Moloney Securities Asset Management, LLC | 18,615 | $22.0K | 0.00% |
| Quilter Plc | 17,010 | $20.0K | 0.00% |
| Rockefeller Capital Management L.P. | 1,000 | $1.00K | 0.00% |
| Bank of America Corp | 22 | $0 | 0.00% |
| FMR LLC | 1 | $0 | 0.00% |
Sold out (10)
Institutions that held Cellectar Biosciences, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Sio Capital Management, LLC | 2,188,058 | $3.52M |
| Silverarc Capital Management, LLC | 606,358 | $976.0K |
| Millennium Management LLC | 246,485 | $397.0K |
| Squarepoint Ops LLC | 136,942 | $220.0K |
| Charles Schwab Investment Management Inc | 22,909 | $37.0K |
| Dimensional Fund Advisors LP | 21,265 | $34.0K |
| Tower Research Capital LLC (TRC) | 15,413 | $25.0K |
| Sowell Financial Services LLC | 17,692 | $24.0K |
| First Foundation Advisors | 10,000 | $16.0K |
| Barclays PLC | 364 | $1.00K |